Monopar Therapeutics
MNPR
MNPR
4 hedge funds and large institutions have $439K invested in Monopar Therapeutics in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
1 | +$216K | |
2 | +$177K | |
3 | +$25K | |
4 |
UBS Group
Zurich,
Switzerland
|
+$21K |
Top Sellers
No sellers this quarter